サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726135

経カテーテル塞栓・閉塞装置の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2025年～2030年

Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Product (Coil, Non-coil),By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 210 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
経カテーテル塞栓・閉塞装置の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント別予測、2025年～2030年
出版日: 2025年04月02日
発行: Grand View Research
ページ情報: 英文 210 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル塞栓・閉塞（TEO）装置市場の成長と動向

Grand View Research, Inc.の最新レポートによると、経カテーテル塞栓・閉塞装置の世界市場規模は、2025～2030年にかけてCAGR 7.7％を記録し、2030年には85億4,000万米ドルに達すると推定されています。

TEO装置市場の主要促進要因には、低侵襲手術の採用増加やがん有病率の上昇が含まれます。

また、血管奇形や線維症など、がん以外の疾患の治療として塞栓術が広く使用されていることが、世界的にTEO装置の需要を促進しています。さらに、効率を高めた技術的に先進的な製品の導入が世界市場の成長を支えています。一方、高コスト、厳しい規制承認手続き、TEO処置の実施には経験豊富な医療専門家が必要であることなどは、開発にマイナスの影響を与えかねない要因のひとつです。

アジア太平洋のTEO装置市場は、医療支出の増加と医療インフラの改善により、最も高いCAGRが見込まれています。アジア太平洋の新興国における医療ツーリズム産業の急速な拡大も、TEO装置の需要を押し上げています。

経カテーテル塞栓・閉塞装置市場レポートハイライト

  • 2024年には、非コイル製品セグメントが52.3%の最大収益シェアで市場を独占し、その多用途性と幅広い臨床用途での有効性に後押しされました。
  • コイル製品セグメントは、様々な血管疾患の治療への応用拡大により、予測期間中にCAGR 7.0%の大幅な成長が見込まれます。
  • 北米は、インターベンショナルラジオロジー（IR）手技の採用増加により、2024年に36.6％の最大収益シェアで世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経カテーテル塞栓・閉塞装置市場の変数、動向、範囲

  • 市場系統の展望
    • 親市場の展望
    • 関連/補助市場展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 経カテーテル塞栓・閉塞装置市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 経カテーテル塞栓・閉塞装置市場：製品別、推定・動向分析

  • 製品セグメントダッシュボード
  • 経カテーテル塞栓・閉塞装置市場：製品変動分析
  • 世界の経カテーテル塞栓・閉塞装置市場規模と動向分析（製品別、2018～2030年）
  • コイル
    • 押し込み可能なコイル
    • 脱着式コイル
  • 非コイル
    • 流れ転換装置
    • 塞栓粒子
    • 液体塞栓
    • その他の塞栓と閉塞装置
    • 付属品

第5章 経カテーテル塞栓・閉塞装置市場：地域別、推定・動向分析

  • 地域別市場ダッシュボード
  • 地域別市場シェア分析、2024年と2030年
  • 地域別経カテーテル塞栓・閉塞装置市場：主要ポイント
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • ベンダー情勢
    • Key Company ヒートマップ分析、2024年
  • 企業プロファイル
    • Boston Scientific Corporation
    • Terumo Corporation
    • Medtronic
    • DePuy Synthes（Johnson & Johnson）
    • Stryker
    • Cordis
    • Abbott
    • Pfizer Inc.
    • Sirtex SIR-Spheres Pty Ltd.
    • Nordion（カナダ）Inc.
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Transcatheter Embolization and Occlusion Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5. North America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 6. North America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 7. U.S. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8. Canada Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9. Mexico Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10. Europe Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 11. Europe Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12. U.K. Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13. Germany Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14. France Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15. Italy Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. Spain Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 17. Denmark Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 18. Sweden Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19. Norway Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22. China Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23. Japan Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. India Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 25. South Korea Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26. Australia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27. Thailand Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28. Latin America Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 29. Latin America Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30. Brazil Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31. Argentina Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 34. South Africa Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 36. UAE Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait Transcatheter Embolization and Occlusion Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Transcatheter Embolization and Occlusion Devices Market: Market Outlook
  • Fig. 10 Transcatheter Embolization and Occlusion Devices Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Transcatheter Embolization and Occlusion Devices Market Driver Impact
  • Fig. 16 Transcatheter Embolization and Occlusion Devices Market Restraint Impact
  • Fig. 17 Transcatheter Embolization and Occlusion Devices Market Strategic Initiatives Analysis
  • Fig. 18 Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • Fig. 19 Transcatheter Embolization and Occlusion Devices Market: Product Outlook and Key Takeaways
  • Fig. 20 Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Pushable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Detachable Coils Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Non Coil Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Flow Diverting Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Embolization Particles Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid Embolics Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Other Embolization and Occlusion Devices Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Accessories Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Global Transcatheter Embolization and Occlusion Devices Market: Regional Movement Analysis
  • Fig. 30 Global Transcatheter Embolization and Occlusion Devices Market: Regional Outlook and Key Takeaways
  • Fig. 31 North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.K. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East & Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Kuwait Market Estimates and Forecasts, 2018 - 2030
目次
Product Code: 978-1-68038-670-7

Transcatheter Embolization And Occlusion Devices Market Growth & Trends:

The global transcatheter embolization and occlusion devices market size is estimated to reach USD 8.54 billion by 2030, registering a CAGR of 7.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR, due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices.

Transcatheter Embolization And Occlusion Devices Market Report Highlights:

  • In 2024, The non-coil product segment dominated the market with the largest revenue share of 52.3%, propelled by its versatility and effectiveness in a wide range of clinical applications.
  • Based product, the coil segment is anticipated to grow at a significant CAGR of 7.0% over the forecast period, driven by its growing application in treating various vascular conditions.
  • North America dominated the global market with the largest revenue share of 36.6% in 2024, attributed to the increased adoption of Interventional Radiology (IR) procedures.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement Analysis
  • 4.3. Global Transcatheter Embolization and Occlusion Devices Market Size & Trend Analysis, By Product, 2018 to 2030 (USD Million)
  • 4.4. Coil
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Pushable Coils
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Detachable Coils
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Non Coil
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Flow Diverting Devices
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Embolization Particles
      • 4.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Liquid Embolics
      • 4.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.5. Other Embolization and Occlusion Devices
      • 4.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.6. Accessories
      • 4.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key Country Dynamics
      • 5.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.1.3. Competitive Scenario
      • 5.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. U.K.
      • 5.5.1.1. Key Country Dynamics
      • 5.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.1.3. Competitive Scenario
      • 5.5.1.4. U.K. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.5.3. Competitive Scenario
      • 5.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Denmark
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.6.3. Competitive Scenario
      • 5.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.7.3. Competitive Scenario
      • 5.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Norway
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 5.5.8.3. Competitive Scenario
      • 5.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. China
      • 5.6.1.1. Key Country Dynamics
      • 5.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.1.3. Competitive Scenario
      • 5.6.1.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.4. South Korea
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.4.3. Competitive Scenario
      • 5.8.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework/ Reimbursement Structure
      • 5.8.5.3. Competitive Scenario
      • 5.8.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/ Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key Company Heat Map Analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Boston Scientific Corporation
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. Terumo Corporation
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Medtronic
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. DePuy Synthes (Johnson & Johnson)
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Stryker
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Cordis
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Abbott
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Pfizer Inc.
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. Sirtex SIR-Spheres Pty Ltd.
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Nordion (Canada) Inc.
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives